COMMUNIQUÉS West-GlobeNewswire

Male Power XL "Black Elixir" Claims Evaluated: 2026 Report Examines Ingredient Research, Proprietary Blend Transparency, and What Men Should Verify Before Buying
04/03/2026
A 2026 informational consumer report evaluating Male Power XL's "black elixir" marketing language, ingredient research context, proprietary blend limitations, pricing and policy terms shown on the official site, and [...]
AudiLeaf Ear Health Claims Evaluated: 2026 Report Examines Ingredients, Proprietary Blend Dosing, and What Consumers Should Verify Before Buying
04/03/2026
A 2026 informational consumer evaluation of AudiLeaf's ear health marketing claims, proprietary herbal blend ingredient research context, pricing structure, and what to verify before purchasing Aurora, CO, March 03, [...]
MemoTril Cognitive Support Claims Evaluated: Latest 2026 Consumer Report Examines MemoTril Brain Supplement Ingredients, Memory Enhancement Marketing, and What Consumers Should Verify
04/03/2026
Informational 2026 consumer report examining MemoTril brain supplement ingredients, cognitive support marketing claims, ingredient research context, pricing disclosures, and what consumers should verify before [...]
DermaFix Nail Fungus Treatment Gel Claims Evaluated in 2026 Market Report Covering Tea Tree Oil Research, Penetration Technology Positioning, and Pricing Transparency
04/03/2026
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and publicly listed pricing structures in the topical nail fungus category Sheridan, WY, March 03 [...]
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
03/03/2026
ZUG, Switzerland, March 03, 2026 (GLOBE NEWSWIRE) -- Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from [...]
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
LifeMD to Participate in Two Investor Conferences During March
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences [...]
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
03/03/2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
03/03/2026
THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners [...]
Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders
03/03/2026
CINCINNATI, March 03, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “ Company ”) (NASDAQ: QIPT; TSX: QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced [...]
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
03/03/2026
Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, evade detection by the [...]
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026
03/03/2026
CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 28 février 2026
03/03/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 28 février 2026 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
ATI Advisory Welcomes Former Wisconsin Medicaid Director Bill Hanna as Practice Director of Payer Strategy and Program Design
03/03/2026
Washington, DC, March 03, 2026 (GLOBE NEWSWIRE) -- ATI Advisory (ATI), a leading healthcare consulting firm, today announced that Bill Hanna has joined the firm as Practice Director of Payer Strategy and Program Design [...]
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
03/03/2026
Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is realized, this settlement [...]
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
03/03/2026
Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic [...]
Vaxart to Host Upcoming Conference Calls
03/03/2026
Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 03, 2026 ( [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2026
NEW YORK and WALTHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
03/03/2026
NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“ InterCure ” or the “ Company ”) today announced that on February 25, 2026 the Company received a written [...]

Pages